Hyperphosphorylation of tau has been suggested to be caused by an increase in kinase activity or by a decrease in phosphatase activity within the neurons during the development of Alzheimer’s disease [126,127], and Arendt et al. [32] reasoned that injection of OA into the brain would increase tau phosphorylation by inhibiting PP2A, since this enzyme is predominantly responsible for the dephosphorylation of this protein [128]. This evidence concerns the gene MAPT and Alzheimer disease.